Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methoxyflurane inhaler for pain reduction during first TRUS prostate biopsy
ACTRN12615001105538Phase 3Completed
- Sponsor
- University of Sydney
- Start
- Jan 2016
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial of methoxyflurane in pain (2 arms), sponsored by University of Sydney. Primary endpoint: Participant-rated pain. Started Jan 2016; status: completed.
02
Drugs
methoxyflurane
03
Conditions
pain
Beyond the preview
Go deeper on ACTRN12615001105538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615001105538.